Home › Upcoming votes › Apimeds Pharmaceuticals US, Inc.
No fund votes on record from prior seasons.
Read the proxy statement on EDGAR
Summary, checked against the proxy statement. Each point is backed by a passage of the filing, shown under the point; figures under “Last year’s votes” come from the company’s Form 8-K. Read the proxy statement before relying on it.
Virtual annual meeting: election of four current directors whose board seats are set by a settlement agreement, auditor ratification and an adjournment proposal.
“the Board will consist of Ms. Kogan, Ms. O'Donnell, Dr. Weintraub and Mr. Chae, and the Company has agreed that no such director will be removed without the written consent of Dr. Vin Menon and the Inscobee Parties” Find it in the filing
“Upon completion of the Preferred Stock Conversion, Ms. Kogan, Ms. O'Donnell and Dr. Weintraub are expected to resign, and the Board is expected to consist of seven directors: four independent directors nominated by MindWave, two directors nominated by Dr. Menon (including Dr. Menon) and Mr. Chae.” Find it in the filing
“Following the Preferred Stock Conversion, Calfin Capital Private Limited is expected to hold more than 50% of the voting power of our outstanding Common Stock, which would result in a change in control of the Company.” Find it in the filing
“If that occurs, we may become a controlled company and may elect to rely on certain of those exemptions.” Find it in the filing
“Mr. Chae is not independent because he serves as our Co-Chief Executive Officer.” Find it in the filing
“Apimeds Inc. and Free T Inc. have granted an irrevocable proxy to Dr. Vin Menon and Capt. Sandeep Singh Yadav to vote their shares with respect to certain matters.” Find it in the filing
“Consideration comprises fees of $1,112,000 payable in four installments of $278,000” Find it in the filing
“The Board has not designated a Chair of the Board or a Lead Independent Director.” Find it in the filing
“Mr. Chae was appointed to the Board on September 10, 2026 upon nomination by the Inscobee Parties.” Find it in the filing
Ballot read from the proxy statement and checked. As listed in Apimeds Pharmaceuticals US, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends |
|---|---|---|---|
| 1 | ELECTION OF DIRECTORS Director election |
Board | For |
| 2 | RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Auditor |
Board | For |
| 3 | ADJOURNMENT PROPOSAL Adjournment |
Board | For |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.